Unity Biotechnology Inc. (UBX) Declined -8.08% or -1.16 To Price $13.2 On Thursday

Unity Biotechnology Inc. (UBX) declined -8.08% or -1.16 to $13.2. It is around 82585 shares traded, which is 67.05% compare to the average total volume 123167. The market cap of UBX is $558.66 million. The year to date change is -21.83%. The 52 week price range is from $10.33 to $24.56. Price of UBX have changed 20.57% during last week. It have changed 11.40% over last month, -19.10% over last 3 months, 2.57% over last 6 months and -13.75% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBX is 12.82. It is -2.88% below current price. The 200-day Moving Averages for UBX is 14.73. It is 11.59% above current price. The 52-week High is 24.56. It is 86.06% from the current price. The 52-week Low is 10.33. It is -21.74% from current price.

There are some statistics of UBX. It is has market cap $558.66 million. The share outstanding is 42.32 million. The average volume is 123167. The percent of top 15 Institution holding is 39.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBX is -37.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBX is -34.42%.


Share this post